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Abstract
Pink1 is a mitochondrial kinase involved in Parkinson’s disease, and loss of Pink1 function affects mitochondrial morphology
via a pathway involving Parkin and components of the mitochondrial remodeling machinery. Pink1 loss also affects the
enzymatic activity of isolated Complex I of the electron transport chain (ETC); however, the primary defect in pink1 mutants
is unclear. We tested the hypothesis that ETC deficiency is upstream of other pink1-associated phenotypes. We expressed
Saccaromyces cerevisiae Ndi1p, an enzyme that bypasses ETC Complex I, or sea squirt Ciona intestinalis AOX, an enzyme that
bypasses ETC Complex III and IV, in pink1 mutant Drosophila and find that expression of Ndi1p, but not of AOX, rescues
pink1-associated defects. Likewise, loss of function of subunits that encode for Complex I–associated proteins displays many
of the pink1-associated phenotypes, and these defects are rescued by Ndi1p expression. Conversely, expression of Ndi1p
fails to rescue any of the parkin mutant phenotypes. Additionally, unlike pink1 mutants, fly parkin mutants do not show
reduced enzymatic activity of Complex I, indicating that Ndi1p acts downstream or parallel to Pink1, but upstream or
independent of Parkin. Furthermore, while increasing mitochondrial fission or decreasing mitochondrial fusion rescues
mitochondrial morphological defects in pink1 mutants, these manipulations fail to significantly rescue the reduced
enzymatic activity of Complex I, indicating that functional defects observed at the level of Complex I enzymatic activity in
pink1 mutant mitochondria do not arise from morphological defects. Our data indicate a central role for Complex I
dysfunction in pink1-associated defects, and our genetic analyses with heterologous ETC enzymes suggest that Ndi1p-
dependent NADH dehydrogenase activity largely acts downstream of, or in parallel to, Pink1 but upstream of Parkin and
mitochondrial remodeling.
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Introduction
Parkinson’s disease (PD (OMIM #168600)) is the most
common neurodegenerative movement disorder [1]. While diverse
processes including autophagy, apoptosis, oxidative stress and
accumulation of protein inclusions have been implicated in the
etiology of the disease, mitochondrial dysfunction appears to play
a central role as well [2–4]. Mitochondrial toxins, such as MPTP
(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) or rotenone, that
block Complex I of the mitochondrial electron transport chain
(ETC) cause clinical features reminiscent of PD in humans and are
commonly used to create animal models of the disease [5,6].
Furthermore, Complex I deficiency is often observed in neurons of
PD patients [7] and mutations in genes causing familial forms of
PD, including pink1 (PARK6, OMIM #605909, Gene ID: 65018),
parkin (PARK2, OMIM #600116, Gene ID: 5071) and DJ-1
(PARK7, OMIM #606324, Gene ID: 11315) result in defects in
mitochondrial morphology and/or function in model organisms
[8–14]. Molecular genetic analyses of PD-associated genes will
thus yield important insights into the mechanisms of PD.
Pink1 (CG4523 Gene ID: 31607) is a serine/threonine kinase
involved in maintaining mitochondrial integrity [8–10] and loss-
of-function mutants show hallmark mitochondrial defects includ-
ing male sterility, an inability of most flies to fly as well as an
inability to maintain synaptic transmission during intense
stimulation, a deficit that can be rescued by supplementing
synapses with ATP [15,16]. The observation of larger clumped
mitochondria in pink1 mutants suggests a model where Pink1 is
involved in the clearance of dysfunctional mitochondria [17–21].
This is in line with experiments that show an alleviation of pink1-
associated phenotypes by over-expression of Parkin (CG10523
Gene ID: 40336), an E3 ubiquitin ligase involved in mitophagy [8–
10] and by the notion that loss-of-function pink1 trumps Parkin
recruitment to mitochondria [18]. Furthermore, the morpholog-
ical defects in pink1 mutants can be modulated by altering the
levels of proteins involved in mitochondrial fusion or fission, and
this is thought to facilitate mitophagy [17,19,21,22]. However,
these studies are not conclusive as functional defects in pink1
mitochondria at the level of Complex I have been observed in the
absence of severe morphological alterations [15,23] and such
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logical alterations [24–26]. These results suggest an alternative
model where functional defects in pink1 mutant mitochondria
precede morphological alterations and mitophagy.
To determine if Pink1 acts to regulate ETC function we
performed genetic studies with heterologous alternative enzymes
that can bypass either Complex I, or Complex III and IV.
Although each of the ETC complexes in flies (and humans)
comprise numerous proteins (Complex I contains more than 40
subunits in humans and in flies), Saccharomyces cerevisiae Ndi1p
(Gene ID: 854919) (UAS-NDI1) constitutes an alternative NADH
oxidoreductase that transfers electrons from NADH to ubiqui-
none, delivering electrons to downstream complexes and therefore
can be used to bypass electron transport in Complex I in higher
order species [27,28]. Similarly, ‘Ciona intestinalis’ alternative
oxidase AOX (Gene ID: 3293227) is able to bypass the
cytochrome c chain and Complexes III and IV by using electrons
from ubiquinol to reduce oxygen [29]. While neither Ndi1p, nor
AOX themselves transfer protons across the inner mitochondrial
membrane, they may add to the proton motive force by facilitating
the ubiquinone cycle, thus contributing to Complex III and IV
mediated proton translocation upon expression of Ndi1p, or to
Complex I mediated proton translocation upon expression of
AOX. Illustrating this idea, expression of Ndi1p in Drosophila can
rescue partial loss-of-function mutations in Complex I components
and confers rotenone resistance [30,31], and expression of AOX
can rescue partial loss-of-function mutations in Complex III and
IV components and confers cyanide resistance [32]. Hence, Ndi1p
and AOX allow us to genetically dissect the ETC.
Here, we assay the role of Complex I in pink1-associated defects
and find that Ndi1p can rescue pink1 phenotypes while AOX
cannot. Similarly, loss-of-function of a Complex I component
phenocopies many of the pink1 mutant phenotypes and these
defects can also be rescued by expression of Ndi1p. In contrast,
expression of Ndi1p fails to rescue parkin mutants, indicating that
Ndi1p acts downstream or in parallel to Pink1 but upstream of
Parkin. Further supporting this model, we do not find reduced
enzymatic activity of Complex I in parkin mutants, and while
modulating mitochondrial remodeling using Drp1 (CG3210 Gene
ID: 33445) or Opa1 (CG8479 Gene ID: 36578) can rescue the
defects in mitochondrial morphology in pink1 mutants, these
manipulations do not rescue decreased enzymatic activity of
Complex I observed in pink1 mutants. Thus, our studies suggest
that the defects at Complex I in pink1 mutants are upstream of
several of the events that lead to pink1-associated phenotypes.
Results
Yeast Ndi1p rescues pink1
Electron transfer activity of the mitochondrial multi-protein
Complex I, NADH:ubiquinone oxidoreductase (EC 1.6.5.3) can
be recapitulated by a single yeast protein, Ndi1p [31,33,34]. To
determine whether the reduced respiratory chain activity in pink1
mutants reported previously [15] are an upstream defect in the
mutants, we generated transgenic flies that harbor a UAS-
Sacharomyces cerevisiae NDI1 construct allowing expression under
the control of GAL4. Quantitative RT-PCR using RNA from flies
that harbor the UAS-NDI1 transgene and the ubiquitously
expressing da-GAL4 driver indicates that NDI1 expression levels
in such animals is similar to that of an endogenously expressed
Complex I component CG3446 (Figure S1A). In addition,
quantitative RT-PCR using RNA of UAS-NDI1 bearing flies, in
the absence of GAL4 also shows low but significant expression of
NDI1 RNA, particularly in the male reproductive organ
(Figure 1A, blue). Ndi1p confers rotenone insensitive NADH
oxidoreductase activity in flies as the enzymatic activity of isolated
Complex I in the presence of rotenone, a Complex I inhibitor,
remains high in mitochondria from flies expressing Ndi1p, but is
dramatically reduced in rotenone-treated mitochondria from
control flies (Figure S1B) [30,31]. Ndi1p expression in Drosophila
is benign as ubiquitous expression (da-GAL4) does not lead to
obvious behavioral or developmental abnormalities (Figure S1C,
S1D). Ndi1p expression rescues lethality associated with RNAi-
induced systemic loss-of-function of CG18624 (Gene ID: 31697),
an evolutionary conserved Complex I component, and also the
mitochondrial defects associated with loss of CG12079 (Gene ID:
38378), another conserved Complex I component (below). These
data confirm that Ndi1p is functional.
Next, we generated pink1 mutant animals that express Ndi1p.
While pink1 mutant males are sterile, low expression of Ndi1p is
sufficient to completely revert this defect (Figure 1B). Given that
pink1 is located on the X-chromosome, homozygous pink1 females
are never observed. However, in the presence of NDI1, fertile
homozygous pink1 female flies are obtained (Figure S2A), whose
genetic makeup we confirmed by genomic PCR (Figure S2B).
Furthermore, while in pink1 mutants morphological defects in
spermatid mitochondria are apparent [10,31], expression of Ndi1p
also rescues these mitochondrial defects (data not shown). Thus,
expression of Ndi1p rescues pink1-associated male sterility and
mitochondrial morphological defects in the germline to a level
indistinguishable from wild type controls.
Drosophila flight muscles require large amounts of metabolic
energy supplied by mitochondria. In adult pink1 mutant flies,
mitochondrial deficits lead to muscle degeneration and a severe
defect to fly. While expression of Ndi1p using da-GAL4 does not
affect flight (Figure S1C), expression in pink1 mutants improves
flight (Figure 1C). Although expression of Ndi1p does not restore
the pink1 flight defect to control levels, it is important to note that
previous experiments demonstrating rescue of Pink1 phenotypes
using over-expressed Parkin showed very similar results [9].
Author Summary
Parkinson’s disease is the most common neurodegenera-
tive movement disorder, and mutations in several genes
are known to cause the disorder. A common theme among
several PD–associated genes is a link to mitochondria,
organelles that use their electron transport chain to
generate ATP. One of the PD–associated genes encodes
a mitochondrial kinase Pink1, but it is not known what the
primary role of Pink1 is within the mitochondria. Indeed,
loss of Pink1 function in cells and model organisms results
not only in mitochondrial morphological defects but also
in an enzymatic deficit at the level of the first protein
complex in the electron transport chain. Here, we express
yeast Ndi1p (an enzyme that can bypass electron transport
in Complex I) and sea squirt alternative oxidase (an
enzyme that can bypass electron transport in Complex
III/IV) in pink1 mutant fruit flies and find that supplement-
ing the mutants with Ndi1p, but not with alternative
oxidase, results in significant rescue of multiple pheno-
types. Conversely, mitochondrial morphological defects in
pink1 mutants are rescued by genetically improving
mitochondrial fission, but this manipulation fails to
improve the enzymatic deficiency at the level of Complex
I. Our data thus pinpoint an important mode of action of
Pink1 at the level of Complex I, and this action at least in
part precedes defects at the level of mitochondrial
remodeling.
Yeast Complex I Rescues pink1 Mutants
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muscles in pink1 mutants as evaluated by decreased indentations in
the thoraces of the flies (Figure S2C). As flight muscle degeneration
correlates with an accumulation of enlarged mitochondria in pink1
mutants [8–10], we labeled the mitochondrial pool using mito-
GFP (Figure 1E). In adult pink1 flight muscles, the mitochondria
appear enlarged and clumped when compared to controls
(Figure 1E, middle) and Ndi1p expression in pink1 mutants
partially trumps this defect (Figure 1E, right). Finally, pink1
mutants that express Ndi1p have an increase in ATP levels
compared to pink1 mutants not expressing Ndi1p (Figure 1D).
Thus, enhanced ATP levels in pink1 mutants that express Ndi1p
may dampen mitochondrial dysfunction and diminish muscle
degeneration.
Previous data indicated that mitochondrial defects cause
synaptic vesicle trafficking and neurotransmitter release defects
at pink1 mutant synapses [15,23]. We therefore measured
neurotransmitter release at the Drosophila third instar neuromus-
cular junction (NMJ). Upon stimulation of the motor neuron at
1 Hz, pink1 mutants, pink1 mutants that express Ndi1p, as well as
control animals that express Ndi1p, show normal neurotransmitter
release as gauged by the amplitude of the excitatory junctional
potential (EJP) (Figure S3A). In contrast, when stimulated at high
frequency (10 Hz), neurotransmitter release in pink1 mutants
gradually declines, in line with a defect to mobilize ‘reserve pool’
(RP, see below) vesicles that are only used under such ‘stressed’
conditions [16,35]. Interestingly, pink1 mutants that express Ndi1p
maintain normal levels of synaptic transmission during a 10 Hz
10 min stimulation paradigm (Figure S3B). These data indicate
that synaptic transmission defects at pink1 mutant NMJs are also
rescued by expression of Ndi1p. As previously shown, this
neurotransmission deficit is likely caused by a lack of mobilization
of the reserve pool synaptic vesicles within NMJ boutons [15]. We
used the fluorescent dye FM 1–43 to label vesicles loaded in the
RP [36] using the stimulation paradigm depicted in Figure 1F
[37]. While pink1 mutants show a significant reduction in RP
vesicle labeling, pink1 mutants that express Ndi1p display labeling
of RP vesicles very similar to controls (Figure 1F, 1G). Thus,
synaptic function deficits in pink1 mutants are alleviated by
expression of yeast Ndi1p.
In pink1 mutant motor neurons, mitochondria are morpholog-
ically normal but show only partial mitochondrial membrane
depolarization [15]. We assessed the mitochondrial membrane
potential in pink1 mutants rescued with Ndi1p using the
ratiometric dye JC-1. [16,38]. Interestingly, compared to pink1
mutants, mitochondria at synaptic boutons of pink1 mutants that
express Ndi1p are significantly more polarized and show more
intense red JC-1 labeling (Figure 1H, 1I). Although Ndi1p itself is
not involved in proton transfer over the inner mitochondrial
membrane, our data indicate that expression of Ndi1p can restore
a negative mitochondrial membrane potential in pink1 mutants.
Potentially Ndi1p improves electron transfer from NADH to
complex III/IV that in turn helps to restore the proton gradient in
mitochondria at synapses.
Expression of AOX does not rescue pink1 mutant
phenotypes
To further test the specificity of Ndi1p-dependent rescue of
pink1-associated phenotypes, we also tested the ability of Ciona
intestinalis AOX to bypass pink1 defects. Our rationale is that AOX
can also transport electrons but at a different site within the ETC:
AOX uses electrons from ubiquinol to reduce oxygen and thereby
bypasses both Complex III and IV [29,32]. We confirm the
functionality of AOX in flies because lethality induced by
expression of RNAi to cyclope (CG14028 Gene ID 46040) that
encodes a Complex IV component, is rescued upon expression of
AOX (data not shown) [32]. Similar to NDI1 we also find basal
expression of AOX in the male reproductive organ that is much
induced by the presence of da-GAL4 (Figure 2A) and ubiquitous
expression of AOX also does not affect flight, muscle degeneration
or the mitochondrial membrane potential (Figure S4A, S4B; see
below). In contrast to Ndi1p, expression of AOX completely fails
to alleviate pink1-associated phenotypes such as male fertility, flight
or mitochondrial morphology (Figure 2B, 2C, 2E Figure S4C).
AOX also does not revert the RP defects in pink1 mutant animals
(Figure 2F, 2G) nor does it alleviate the reduced red JC-1 labeling
observed in mitochondria at boutons of pink1 mutants (Figure 2H,
2I). Finally, also the reduced ATP levels, observed in pink1 mutant
animals, are not rescued by AOX (Figure 2D). Thus, AOX
expression does not rescue pink1 deficiency.
Downregulation of a Complex I component phenocopies
many pink1 mutant phenotypes
Our work suggests that several pink1 mutant phenotypes stem
from defects at the level of Complex I. To further test this
hypothesis, we used RNAi mediated knock down of evolutionary
conserved Complex I subunits (Figure 3A). As expected, down
regulation of Complex I subunits results in significantly lower
Complex I enzymatic activity (Figure 3B) and expression of NDI1
in these flies results in an increased ATP concentration compared
to RNAi of Complex I subunits in the absence of NDI1 expression
(Figure 3C). While expression of RNAi to some of the Complex I
subunits results in developmental lethality, RNAi to other
Complex I subunits yields adult flies, and we used one of those
(CG11455; Gene ID: 33179) to assess flight upon Complex I knock
Figure 1. NDI1 transgene is expressed and rescues pink1 mutant phenotypes. (A) Quantitative RT-PCR using primers to CG3446,a
component of ETC Complex I and to NDI1, in testes using tissue of the following genotypes w; da-Gal4 (green)/+, w; UAS-NDI1 (orange) and w; UAS-
NDI1/+; da-Gal4/+ (blue). Data normalized to housekeeping genes (see Text S1). (B) Quantification of fertility of w pink1
RV control male flies of w
pink1
B9and of w pink1
B9; UAS-NDI1 male flies. ‘‘RV’’: wild type pink1 gene (precise P element excision); ‘‘B9’’: mutant pink1
B9 allele (n=30 animals). (C)
Quantification of flight in control (w pink1
RV; da-Gal4/+)i npink1
B9 mutant (w pink1
B9; da-Gal4/+) and in pink1
B9 mutant flies that express Ndi1p (w
pink1
B9; UAS-NDI1/+; da-Gal4/+). Student’s t-test: * p,0.05. Error bars SEM, n=10 experiments with 5 flies each. (D) Relative ATP levels of pink1
B9
mutant flies (w pink1
B9; da-Gal4/+) normalized to pink1
RV control flies (w pink1
RV; da-Gal4/+) and of pink1
B9 mutant flies that express Ndi1p (w pink1
B9;
UAS-NDI1/+; da-Gal4/+) normalized to control flies that express Ndi1p (w; UAS-NDI1/+; da-Gal4/+). Student’s t-test: * p,0.05. Error bars SEM, n=3
experiments with 5 flies each. (E) GFP labeling of mitochondria from the adult indirect flight muscles of the following genotypes w pink1
RV; UAS-
mito:GFP/+; da-Gal4/+ and w pink1
B9; UAS-mito:GFP/+; da-Gal4/+ and w pink1
B9; UAS-mito:GFP/UAS-NDI1; da-Gal4/+. (F,G) Quantification (F) and
labeling (G) of Reserve Pool (RP) vesicles in pink1
RV controls (w pink1
RV; da-Gal4/+) in larvae expressing the NDI1 transgene (w; UAS-NDI1/+; da-Gal4/+),
in pink1
B9 mutants (w pink1
B9; da-Gal4/+) and in pink1
B9 mutants expressing Ndi1p (w pink1
B9;UAS-NDI1/+; da-Gal4/+), using the stimulation protocol
shown on the left (methods). Student’s t-test: * p,0.05; ns, not significant. Error bars SEM, n.8 synapses from 4 animals. (H,I) Quantification of red to
green JC-1 fluorescence (H) and examples (I) at NMJ boutons in larvae of the genotypes indicated in (F–G). Student’s t-test: *** p,0.0001; ns, not
significant. Error bars SEM, n.16 synapses from 4 animals.
doi:10.1371/journal.pgen.1002456.g001
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this Complex I subunit does not result in a strong defect to fly (blue
bar Figure 3D), however under more ‘stringent conditions’ (see
methods) about half of the flies fail to fly, and this defect is rescued
by expression of NDI1 (red bars Figure 3D). Thus, while reduced
Complex I activity results in a defect to fly, the flight deficit upon
knock down of this Complex I subunit is milder than that observed
in pink1 mutants (Figure 3E).
Next, we determined mitochondrial morphology using Mito-
GFP in third instar larval muscles upon knock down of a Complex
I subunit. Similar to mitochondria in pink1 mutants, mitochondria
in muscles of animals that express RNAi to a Complex I subunit
are swollen and clumped, but the defects we observe are in general
less severe than those seen in pink1
B9 null mutants. Interestingly,
expression of NDI1 significantly alleviates these defects (Figure 3F).
To assess mitochondrial function in animals that express RNAi to
a Complex I subunit with or without NDI1, we assessed the
mobilization of RP vesicles and we quantified red JC-1 labeling
intensity within neuromuscular mitochondria. As indicated in
Figure 3G–3J, reduced Complex I activity results in reduced RP
vesicle mobilization and less red JC-1 labeling in boutonic
mitochondria, and expression of NDI1 can significantly rescue
these defects as well. Thus, similar to pink1 mutants, loss-of-
function of a component of Complex I results in reduced ATP and
functional defects in synaptic mitochondria, and these defects are
alleviated by NDI1p. Furthermore, we also find that reduced
Complex I activity leads to morphological defects in muscular
mitochondria and a defect to fly in adult flies, but these defects are
in general milder than those observed in pink1 null mutants.
Expression of NDI1 does not rescue parkin mutant
phenotypes
Pink1 has been suggested to act upstream of Parkin to regulate,
in a linear pathway, mitophagy [8–10,39,40]. We therefore
expressed Ndi1p in parkin mutant flies but we did not observe a
rescue of male fertility, flight defects or muscular degeneration
(Figure 4A, 4B, 4D). In line with these observations, mitochondrial
morphological alterations caused by Parkin deficiency are also not
rescued by expression of Ndi1p (Figure 4C). Thus, parkin mutants
cannot be rescued by expression of Ndi1p.
To determine if parkin mutants also display reduced enzymatic
activity of Complex I we isolated mitochondria from parkin null
mutant flies and from controls and measured Complex I
enzymatic activity. In contrast to pink1 mutants, the isolated
enzymatic activity of Complex I in parkin mutant mitochondria is
similar to controls (Figure 4E). These data are in further support of
a model where Complex I defects in pink1 mutants occur upstream
from the defects caused by loss of Parkin function.
Modulation of mitochondrial morphology does not
rescue Complex I defects in pink1 mutants
Previous reports indicate that genetic manipulation of the
mitochondrial remodeling machinery using over expression of drp1
or loss-of-function of opa1 alleviates mitochondrial morphological
defects, muscle degeneration and flight deficits both in pink1 and in
parkin mutant flies [17,19] and we confirm these results (Figure 5A,
5B, data not shown). In contrast however, sterility of pink1 mutant
males is not rescued by increased drp1 or decreased opa1
(Figure 5C), suggesting that manipulation of mitochondrial
remodeling cannot rescue all pink1-related phenotypes. As
mitochondrial morphological phenotypes may result from alter-
ations in numerous biochemical pathways [26], we assessed
directly whether drp1 or opa1 affect the enzymatic activity of
Complex I in pink1 mutant flies. However, as shown in Figure 5D,
the enzymatic activity of Complex I is still reduced to a level
similar to that observed in pink1 mutants. These data thus indicate
that the enzymatic deficiency at the level of Complex I in pink1
mutants precedes mitochondrial morphological deficits, or that
they in part occur independently.
Discussion
In this work we present compelling evidence that the
mitochondrial kinase Pink1 is critically required to maintain
efficient Complex I enzymatic activity in mitochondria and that
this function precedes mitochondrial remodeling or mitophagy
(Figure 5E). While Pink1 likely acts via multiple (phospho-) targets
[41,42], our data suggests a pathway in which many of the
deficiencies in pink1 can be traced back to mitochondrial
dysfunction [8–10,15].
Our experiments indicate that Pink1 acts at, or in parallel to,
Complex I, in line with the reduced enzymatic activity of this
complex in pink1 mutant mouse cells and flies [15,23]. Expression
of Ndi1p alleviates many pink1-associated phenotypes, suggesting
that more efficient electron transport between NADH and
ubiquinone is mediated by Ndi1p (bypassing the endogenous
Complex I deficiency) [30] in pink1 mutants that boosts formation
of a proton gradient by Complex III and IV. Although AOX
expression also improves ETC efficiency [32], it does not rescue
pink1-associated phenotypes, in contrast to AOX rescuing DJ-1b
(CG1349 Gene ID: 43652) and cyclope associated phenotypes [32].
The lack of rescue is likely not due to the fact that AOX is
insufficiently activated as a result of low reduced ubiquinone
concentrations [43] as expression of AOX in pink1 mutants results
in premature death of pink1 animals such that only few pink1
mutants that express AOX emerge as adults (data not shown). We
surmise that the lower Complex I activity in pink1 mutants, which
results in reduced proton transfer across the inner mitochondrial
Figure 2. AOX does not rescue pink1 mutants. (A) Quantitative RT-PCR using primers to CG3446 and to AOX, in testes using tissue of the
following genotypes w; da-Gal4/+ (green), w; UAS-AOX (orange) and w; UAS-AOX/+; da-Gal4/+ (blue). Data normalized to housekeeping genes (see
Text S1). (B) Quantification of fertility of w pink1
RV control male flies of pink1
B9and of w pink1
B9; UAS-AOX male flies (n=20 animals). (C) Quantification
of flight in control (w pink1
RV; da-Gal4/+)i npink1
B9 mutant (w pink1
B9; da-Gal4/+) and in pink1
B9 mutant flies that express AOX (w pink1
B9; UAS-AOX/+;
da-Gal4/+). Student’s t-test: ns, not significant. Error bars SEM, n=6 experiments with 5 flies each. (D) Relative ATP levels of pink1
B9 mutant flies (w
pink1
B9; da-Gal4/+) normalized to pink1
RV control flies (w pink1
RV; da-Gal4/+) and of pink1
B9 mutant flies that express AOX (w pink1
B9; UAS-AOX/+; da-
Gal4/+) normalized to control flies that express AOX (w; UAS-AOX/+; da-Gal4/+). Student’s t-test: ns, not significant. Error bars SEM, n=3 experiments
with 5 flies each. (E) GFP labeling of mitochondria from the adult indirect flight muscles of the following genotypes w pink1
RV; UAS-mito:GFP/+; da-
Gal4/+ and w pink1
B9; UAS-mito:GFP/+; da-Gal4/+ and w pink1
RV; UAS-mito:GFP/UAS-AOX; da-Gal4/+. (F,G) Quantification (F) and labeling (G) of Reserve
Pool (RP) vesicles in pink1
RV controls (w pink1
RV; da-Gal4/+) in larvae expressing the AOX transgene (w; UAS-AOX/+; da-Gal4/+), in pink1
B9 mutants (w
pink1
B9; da-Gal4/+) and in pink1
B9 mutants expressing AOX (w pink1
B9; UAS-AOX/+; da-Gal4/+), using the stimulation protocol shown on the left.
Student’s t-test: * p,0.05; ns, not significant. Error bars SEM, n.8 synapses from 4 animals. (H,I) Quantification of red to green JC-1 fluorescence (H)
and examples (I) at NMJ boutons in larvae of the genotypes indicated in (F–G). Student’s t-test: ns, not significant. Error bars SEM, n.16 synapses
from 4 animals.
doi:10.1371/journal.pgen.1002456.g002
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that transfers electrons to oxygen without pumping protons [29].
These data thus argue against general mitochondrial dysfunction
in pink1 and a universal failing of the ETC [23] but reveals an
important role for Pink1 upstream or in parallel to Complex I
enzymatic activity [15].
Previous work indicates that loss of pink1 in some cell types
results in mitochondrial fragmentation, a process preceding
mitophagy [44]. Several lines of evidence now indicate that some
of the mitochondrial morphological defects occur downstream of
functional deficits in pink1 mutants. First, we show that expression
of Ndi1p in pink1 mutants alleviates part of the mitochondrial
morphological defects. Second, RNAi-mediated knock down of an
evolutionary conserved Complex I component results in mito-
chondrial dysfunction but also mitochondrial swelling and
clumping, indicating that functional mitochondrial defects can
lead to morphological defects [24,26,45]. Third, mitochondrial
functional defects in pink1 mutant flies and mice have been widely
observed in neuronal populations where mitochondrial morpho-
logical defects are not (yet) prevalent [15,23]. Fourth, while
facilitating mitochondrial fission in pink1 mutants alleviates
mitochondrial morphological defects, a deficiency at the level of
the enzymatic activity of Complex I persists. Previous results in
pink1 knock out cells had also indicated that mitochondrial swelling
defects in pink1 mutant cells can be rescued by modulating the
levels of the mitochondrial fission machinery [46], but also this
manipulation failed to rescue the defect in mitochondrial
membrane potential caused by loss of Pink1 [47]. Thus, our data
indicate that the upstream molecular dysfunction in pink1 mutants
on Complex I is a major culprit in the development of the pink1
mutant phenotypes (Figure 5E).
Our rescue experiments indicate that expression of NDI1 can
significantly rescue numerous pink1 associated phenotypes, includ-
ing male sterility, vesicle trafficking and mitochondrial membrane
potential. Likewise, NDI1 also alleviates mitochondrial morpho-
logical defects in pink1 mutant muscles, but rescue of this
morphological defect is only partial. Similarly, mitochondrial
morphological defects observed in animals that express RNAi to a
Complex I subunit and flight defects in such animals are in general
less severe than those seen in pink1 null mutants. These results are
consistent with Pink1 also acting in parallel to its role at the level of
Complex1; however, we cannot exclude the possibility that the
partial rescue of morphological defects in pink1 mutants upon
expression of NDI1 originates from an incomplete reconstitution of
ETC activity under these conditions, and that the pink1 mutant
conditions at the level of Complex I may not be exactly
recapitulated by knock down of the Complex I components.
Furthermore, given that Complex I dysfunction results in
mitochondrial morphological defects and mild flight defects that
are rescued by NDI1 expression, and the observation that the
enzymatic defects at the level of Complex I in pink1 mutants are
not rescued upon expression of Drp1 or loss of opa1 function, the
data are consistent with the pink1-associated Complex I defects to
act at least in part upstream of remodeling and suggest an
important and central role for Complex I in Pink1 induced
mitochondrial pathology.
Our work expands on previous genetic and cell biological
studies, and indicates that Pink1 can act at a different level,
upstream of Parkin, to control Complex I enzymatic activity
(Figure 5E). Indeed, unlike pink1 mutants, loss of parkin in flies does
not cause significantly reduced enzymatic activity of Complex I
seen in pink1 mutants, and in addition, parkin loss of function is not
rescued by expression of Ndi1p. Our data indicate that Complex I
deficiency in pink1 mutants is specific and that this defect is not a
result of abnormal mitochondrial remodeling or mitophagy. This
model is consistent with a role of Pink1 in controlling
mitochondrial health and also does not exclude a downstream
or parallel role where Pink1 can be triggered to recruit Parkin,
facilitating mitophagy (Figure 5E).
Materials and Methods
Drosophila stocks and maintenance
w; UAS-mito:GFP, w; da-Gal4 and w; P{lacW}opa1-like
3475/CyO
(opa1
S3) were obtained from Bloomington stock center (Indiana, USA);
w pink1
B9 and w pink1
RV, parkin
1 and parkin
RV [48] were gifts from
Jongkyeong Chung (Korea, Advanced Institute of Science and
Technology) [9] and parkin
D21 m u t a n tf l i e sw e r eag i f tf r o mG r a e m e
Mardon (Baylor College of Medicine) [11]. drp1
+ genomic rescue
constructs were provided by Hugo Bellen (Baylor College of Medicine)
[16] and w
1118;U A S - A O X
F6 were a gift from Howard T. Jacobs [32]
(Finland, Institute of Medical Technology, Tampere University
Hospital). w
1118; UAS-CG12079
RNAi (w
1118; P{GD5910}v13856),
w
1118; UAS-CG11455
RNAi (w
1118; P{GD4800}v12838)a n dcyclope
(CG14028)R N A i( w
1118; P{GD908}v13403) were from the Vienna
Drosophila RNAi Center (VDRC) [49]. Flies were raised on standard
cornmeal and molasses medium.
Generation of UAS-NDI1 transgenic flies
The coding region of Saccaromyces cerevisiae NDI1 was amplified
from yeast genomic DNA (Patrick Van Dijck, VIB Leuven), with
the following primers; CGG AAT TCC AAA ATG CTA TCG
AAG and GGC GGC CGC CTA TAA TCC TTT A using 2 X
BIO-X-ACT Short Mix (BIOLINE), cloned in the EcoR1 and
Not1 of pUAST-Attb (43) and sequenced. Transgenic flies were
Figure 3. RNAi to a Complex I component (CG12079) phenocopies pink1 mutants and is rescued by Ndi1p expression. (A) Quantitative
RT-PCR using primers to CG12079 in w; da-Gal4/+ (green) and w; UAS- CG12079
RNAi/da-Gal4 (orange) larvae. Data normalized to housekeeping genes
(see methods). (B) Complex I enzymatic activity measurement of whole third instar larval mitochondrial homogenates from w controls and Complex I
deficient RNAi flies (w; da-Gal4/UAS-CG12079
RNAi). Student’s t-test: * p,0.05. Error bars SEM, n=3 experiments with 50 larvae each. (C) Relative ATP
levels of w; UAS-CG12079
RNAi/da-Gal4 normalized to control w; da-Gal4/+ and of w; UAS-NDI1/+; UAS-CG12079
RNAi/da-Gal4 normalized to control flies
w; UAS-NDI1/+; da-Gal4/+. Student’s t-test: * p,0.05. Error bars SEM, n=3 experiments with 5 larvae each. (D,E) Quantification of flight in w; da-Gal4/+
controls, in Complex I RNAi expressing flies (w; UAS-CG11455
RNAi; da-Gal4), in Complex I RNAi expressing flies that also express NDI1 (w; UAS-NDI1,
UAS-CG11455
RNAi; da-Gal4) (D), in pink1
RVcontrols and in pink1
B9 mutants (E) under ‘standard testing conditions’ (blue bars) and under ‘stringent
testing conditions’ (red bars). Student’s t-test: * p,0.05; ** p,0.01; *** p,0.001. Error bars SEM, n=6 experiments with 5 flies each. (F) GFP labeling of
mitochondria from the larval body wall muscles of controls (w; da-Gal4, UAS-mito:GFP/+), Complex I RNAi expressing flies (w; da-Gal4, UAS-mito:GFP/
UAS-CG12079
RNAi) and Complex I RNAi expressing flies that also express NDI1 (w; UAS-NDI1; da-Gal4, UAS-mito:GFP/UAS-CG12079
RNAi). (G,H)
Quantification (G) and RP vesicle labeling (H) in controls (w; da-Gal4/+)i nw; da-Gal4/UAS-CG12079
RNAi and in w; UAS-NDI1; da-Gal4/UAS-CG12073
RNAi.
Student’s t-test: * p,0.05; ns, not significant. Error bars SEM, n.8 synapses from 4 animals. (I,J) Quantification of red to green JC-1 fluorescence (I)
and examples (J) at NMJ boutons in larvae of the genotypes indicated in (G–H). Student’s t-test: *** p,0.001 Error bars SEM, n.16 synapses from 4
animals.
doi:10.1371/journal.pgen.1002456.g003
Yeast Complex I Rescues pink1 Mutants
PLoS Genetics | www.plosgenetics.org 8 January 2012 | Volume 8 | Issue 1 | e1002456Figure 4. Ndi1p does not rescue parkin mutants. (A) Quantification of fertility of w; parkin
RV control male flies of w; park
1/D21 and of w; UAS-NDI1;
park
1/D21 male flies. ‘‘RV’’: wild type parkin (precise P element excision); ‘‘1/D21’’; mutant park
1/D21 heteroallelic combination (n=30 animals). (B)
Quantification of flight in control (w; da-Gal4, park
RV)i npark
1/D21 mutant (w; da-Gal4, park
D21/park
1) and in park
1/D21 mutant flies that express Ndi1p
(w; UAS-NDI1/+; da-Gal4, park
D21/park
1). Student’s t-test: * p,0.05. Error bars SEM, n=10 experiments with 5 flies each. (C) GFP labeling of
mitochondria from the adult indirect flight muscles of the following genotypes UAS-mito:GFP/+; da-Gal4, park
RV and UAS-mito:GFP/+; da-Gal4,
park
D21/park
1 and UAS-mito:GFP/UAS-NDI1; da-Gal4, park
D21/park
1. (D) Quantification of thorax indentations of genotypes indicated in (A). Student’s t-
test: * p,0.03. Error bars SEM, n=10 experiments with 5 flies each. (E) Complex I enzymatic activity measurement of whole fly-mitochondrial
homogenates from pink1
RV controls and pink1
B9 mutants compared to park
RV controls and park
1/D21 mutants. Student’s t-test: * p,0.05; ns, not
significant. Error bars SEM, n.6 experiments with 50 flies each.
doi:10.1371/journal.pgen.1002456.g004
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mediated transgenesis in the VK1 docking site (2R, 59D3) [50].
Quantitative RT–PCR
Testis samples from w; daGal4/+ and w; UAS-NDI1 and w; UAS-
NDI1/+; da-Gal4/+ and w; UAS-AOX
F6 and w; UAS-AOX
F6/+; da-
Gal4/+ adult flies were micro-dissected in ice-cold PBS followed by
snap-freezing on dry ice. Third instar larvae from w; daGal4/+ and
w; UAS-CG12079
RNAi/da-Gal4 were also snap-frozen on dry ice. Q-
RT-PCR was performed using standard procedures, as outlined in
Text S1, and relative RNA levels were calculated according to the
DDCt method. Primers are listed in Table S1.
Sterility test
Single males (30) of the genotypes indicated in the figure legends
were crossed to 1–3 day old w
1118 virgins and a score of 1 was
assigned when offspring was detected.
Flight assays
For flight assays, batches of 5 freshly eclosed male flies grown at
18uC of the genotypes indicated in the figure legends were put at
room temperature for 2 days and then transferred to an empty vial
(5 cm D, 10 cm H). For ‘standard testing conditions’, flies were
allowed to climb above a marked line at 9 cm height, the vial was
gently tapped and visually scored for flying flies over the next
minute. For more ‘stringent testing conditions’ flies were allowed
to climb above a marked line at 9 cm height, and flying flies were
scored immediately following tapping of the vial. Flies at the
bottom were removed and the remaining flies were retested. Flies
that fly twice were assigned a score of 1, the others a score of 0.
Student’s t test was used to assess the statistical differences.
ATP measurements
Five third instar larvae or five thoraces from 2–3 days-old flies
were dissected and homogenized in 50 ml of 6 M guanidine-HCl
Figure 5. Increased mitochondrial fission does not rescue reduced Complex I enzymatic activity of pink1 mutants. (A) Quantification of
flight in control (w pink1
RV)i npink1
B9 (w pink1
B9) and in pink1
B9 mutant flies that either have a genomic rescue construct of drp1 (drp1
+) or have one
mutant allele of opa1 (opa1
S3)( w pink1
B9; drp1
+/+ and w pink1
B9; opa1
S3/+). Student’s t-test: ** p,0.01; * p,0.05. Error bars SEM, n=10 experiments
with 5 flies each. (B) Quantification of thorax indentations of genotypes indicated in (A). Student’s t-test: ** p,0.01; *** p,0.001. Error bars SEM,
n=10 experiments with 5 flies each. (C) Quantification of fertility of w pink1
RV control male flies, w pink1
B9 mutants and of w pink1
B9; drp1
+/+ and of w
pink1
B9; opa1
S3/+ resp. male flies (n=30 animals). (D) Complex I enzymatic activity measurement of whole fly mitochondrial homogenates from w
pink1
RV controls and w pink1
B9 mutants compared to w pink1
RV; drp1
+/+ controls, w pink1
B9; drp1
+/+ mutants and w pink1
RV; opa1
S3/+ controls, w
pink1
B9; opa1
S3/+ mutants. Student’s t-test: * p,0.05. Error bars SEM, n.3 experiments with 50 flies each. The data for w pink1
RV and w pink1
B9 is
identical to that shown in Figure 4E. (E) Model of Pink1 and Parkin function in the regulation of mitochondrial activity. Our work indicates that Pink1
has an important function at the level of Complex I, and these defects in part result in mitochondrial remodeling defects seen in the mutants.
doi:10.1371/journal.pgen.1002456.g005
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were snap-frozen in liquid nitrogen and then boiled for 3 min.
Samples were then centrifuged and the supernatant was diluted
(1/50) in extraction buffer, mixed with luminescent solution (ATP
Determination Kit, Invitrogen) and luminescence was measured
on an EnVision Multilabel Reader (Perkin Elmer). Luminiscence
was normalized to protein amount (mg) (Bradford) and compared
to ATP standards. n=3. Student’s t test was used to assess the
statistical differences.
Microscopy
Thoraces of adult flies were viewed under an Olympus SZX12
microscope equipped with a DF PLAPO 1X PF lens and the
pictures were captured with an Olympus U-CMAD3 camera.
Mitochondrial morphology in adult flight muscles of flies grown
at 18uC and reared at room temperature for 2 days or in
wandering third instar larvae grown at 25uC was assessed by
visualizing mitochondrial tagged GFP (mito-GFP), excited using
488 nm laser light and imaged on a Zeiss LSM 510 META
confocal microscope using a 636oil NA 1.4 lens (for adult muscles)
or a 406oil NA 1.3 lens (for larvae) using a 500–530 band pass
emission filter.
RP vesicles of larvae were labeled by electrically stimulating
motor neurons of third instar larval fillets in HL-3 with 2 mM
Ca
2+ for 10 min at 10 Hz and then leaving the preparation to rest
for 5 min in the presence of the dye following stimulation. This
protocol labels the entire vesicle pool; the exo-endo cycling pool
(ECP) and the RP. To unload the FM 1–43 from the ECP, leaving
RP labeling intact, preparations were subsequently incubated for
5 min in HL-3 with 90 mM KCl and 2 mM Ca
2+ (in the absence
of FM 1–43) [16]. Following washing in Ca
2+ free HL-3, NMJs
were imaged on a Nikon FN-1 microscope with a DS-2MBWc
digital camera, 406W NA 0.8 objective and quantification of
labeling intensity was performed using NIS-Elements AR 3.10.
JC-1 (Molecular Probes) labeling was performed on wandering
third instar larvae of the genotypes indicated in the figure legends
as described previously [15]. Red and green fluorescence was
captured on a Nikon FN-1 microscope with a Hamamatsu
ORCA-R
2, 40W NA 0.8 objective. Quantification of red and
green labeling intensity was performed using NIS-Elements AR
3.10.
Enzymatic Complex I activity measurements
Complex I activity measurements were performed as described
[15]. Data represent at least 3 independent experiments where
mitochondrial preparations from 50 animals were prepared for
each independent experiment. The Complex I enzymatic activity
was normalized to Citrate Synthase enzymatic activity.
Supporting Information
Figure S1 Expression of NDI1 is benign and rescues Complex I
defects. (A) Quantitative RT-PCR using primers to CG3446,a
component of ETC Complex I and to NDI1, in whole flies using
tissue of the following genotypes w; da-Gal4 (green), w; UAS-NDI1
(orange) and w; UAS-NDI1; da-Gal4 (blue). Data normalized to
housekeeping genes (Text S1). (B) Complex I enzymatic activity
measurements in mitochondrial homogenates of control (w
pink1
RV; da-Gal4), w; UAS-NDI1; da-Gal4, w pink1
B9; da-Gal4 and
w pink1
B9; UAS-NDI1; da-Gal4 in the absence of Rotenone (green)
and presence of Rotenone (orange). Student’s t-test: * p,0.05;
** p,0.01; ns=non-significant. Data represent the average +/2
SEM of n=3 experiments with 50 flies each. (C) Quantification of
flight in w; UAS-NDI1; da-Gal4 flies and w; da-Gal4/+ controls.
Data represent the average +/2 SEM of n=10, (5 flies per
independent test assayed). ns=non-significant. (D) Quantification
of thorax indentations in NDI1 expressing flies: w; UAS-NDI1; da-
Gal4 and da-Gal4/+ controls. Data represent the average +/2
SEM of n=6 (5 flies per independent test assayed). ns=non-
significant.
(TIF)
Figure S2 Expression of NDI1 rescues sterility and indentation
phenotypes of pink1 mutant flies. (A) Images of hemizygous male w
pink1
RV, w pink1
B9 and w pink1
B9; UAS-NDI1 flies and of
homozygous female w pink1
RV and w pink1
B9; UAS-NDI1 flies.
na=not applicable. (B) PCR on genomic DNA from w pink1
RV
males (lane 1), w pink1
B9/+ heterozygous females (lane 2), w pink1
B9
hemizygous males (lane 3) and w pink1
B9; UAS-NDI1 homozygous
females (lane 4) using primers to amplify the pink1 locus, the NDI1
transgene and male fertility factor kl3 on the Y chromosome (Text
S1). Primers used are listed in Table S1. (C) Quantification of
thorax indentations in control (w pink1
RV; da-Gal4/+)i npink1
B9
mutant (w pink1
B9; da-Gal4/+) and in pink1
B9 mutant flies that
express Ndi1p (w pink1
B9; UAS-NDI1/+; da-Gal4/+). Student’s t-
test: * p,0.05. Data represent the average +/2 SEM of n=10
experiments with 5 flies each.
(TIF)
Figure S3 Expression of NDI1 rescues pink1 mutant defects in
neurotransmitter release. (A) Quantification of the amplitude of
excitatory junctional potentials measured in 2 mM external
calcium in pink1
RV controls (w pink1
RV; da-Gal4/+), in larvae
expressing NDI1 (w; UAS-NDI1/+; da-Gal4/+), in pink1
B9 mutants
(w pink1
B9; da-Gal4/+) and in pink1
B9 mutants expressing NDI1 (w
pink1
B9; UAS-NDI1/+; da-Gal4/+). Student’s t-test: ns=non-
significant. Data represent the average +/2 SEM of n=4 animals
(8 NMJs). (B) Relative EJP amplitudes measured in 2 mM Ca
2+
during 10 min of 10 Hz stimulation in controls, pink1
B9 mutants,
pink1
B9 mutants expressing NDI1 and controls expressing NDI1
(genotypes, see A). EJP amplitudes were binned per 30 s and
normalized to the average amplitude of the first 10 EJPs. Data
represent the average +/2 SEM of n=4 animals (8 NMJs).
(TIF)
Figure S4 Expression of AOX is benign. (A) Quantification of
flight in w; UAS-AOX/+; da-Gal4/+ and in w; da-Gal4/+ controls.
Data represent the average +/2 SEM of n=6 (5 flies per
independent test). Student’s t-test: ns=non-significant. (B) Quan-
tification of indentations in w; UAS-AOX/+; da-Gal4/+ and in w;
da-Gal4/+ controls. Data represent the average +/2 SEM of n=6
(5 flies per independent test). Student’s t-test: ns=non-significant.
(C) Quantification of thorax indentations in control (w pink1
RV; da-
Gal4/+)i npink1
B9 mutant (w pink1
B9; da-Gal4/+) and in pink1
B9
mutant flies that express AOX (w pink1
B9; UAS-AOX/+; da-Gal4/+).
Student’s t-test: ns=non-significant. Data represent the average
+/2 SEM of n=6 experiments with 5 flies each.
(TIF)
Table S1 Primers used for Q-RT-PCR and PCR from genomic
DNA. List of primers used for Q-RT-PCR and of primers used for
PCR of genomic DNA.
(DOC)
Text S1 Supplemental methods.
(DOC)
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